Zenalpha®
(medetomidine and vatinoxan hydrochlorides injection)
Zenalpha® features a unique mechanism of action that helps minimize cardiovascular effects. Medetomidine is an alpha-2 agonist responsible for sedative and analgesic properties whereas Vatinoxan is an alpha-2 antagonist, acting in the periphery without crossing the blood-brain barrier. Dogs should be monitored frequently during sedation for changes in heart rate, blood pressure, respiratory rate and body temperature.